Humanized antibody molecules to CD138 and uses thereof

MYPI2025003431A0Undetermined Publication Date: 2020-12-17VISTERRA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003431
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-06-05
Filing Date
2020-06-17
Publication Date
2020-12-17
Patent Text Reader

Abstract

Humanized antibody molecules that specifically bind to CD138 are disclosed. The humanized antibody molecules can be used to treat, prevent, and / or diagnose disorders, such as multiple myeloma. Fig. 1
Need to check novelty before this filing date? Find Prior Art